The ß-globin locus control region in combination with the EF1a short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity. (2012)
Attributed to:
Development of a lentiviral vector for gene therapy of ADA deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/mt.2012.50
PubMed Identifier: 22434141
Publication URI: http://europepmc.org/abstract/MED/22434141
Type: Journal Article/Review
Volume: 20
Parent Publication: Molecular therapy : the journal of the American Society of Gene Therapy
Issue: 7
ISSN: 1525-0016